Entera Health Provides Update on Recruitment for HIV Enteropathy Trial

Entera Health, Inc. announced today that the number of patients enrolled into a study to evaluate the impact of EnteraGama , a serum-derived bovine immunoglobulin/ protein isolate , on HIV-associated enteropathy has surpassed the midpoint of recruitment.

http://www.businesswire.com/portal/site/topix/index.jsp?ndmViewId=news_view&newsId=20131112005363&newsLang=en&ndmConfigId=1000639&vnsId=41